Availability of Transgene’s 2022 Universal Registration Document

STRASBOURG, France--()--TRANSGENE (Paris: TNG) today announced that its Universal registration document for fiscal year ended December 31, 2022, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.23-0237.

The 2022 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company’s website: www.transgene.fr, in the “Investors/Financial information” section and on the AMF website: www.amf-france.org.

It includes:

- the 2022 annual financial report;

- the report of the Board of Directors on corporate governance;

- the statutory auditor’s reports;

- information on the share buyback program;

- information related on the auditor’s fees.

The universal registration document also includes information on the Company’s environmental and social responsibility.

Contacts

Transgene:
Lucie Larguier
Director Corporate Communications & IR
+33 (0)3 88 27 91 04
investorrelations@transgene.fr

$Cashtags

Contacts

Transgene:
Lucie Larguier
Director Corporate Communications & IR
+33 (0)3 88 27 91 04
investorrelations@transgene.fr